Angiography Equipment Market Size & Share 2025 – 2034

Angiography Equipment Market Size

The global angiography equipment market size was valued at USD 12.5 billion in 2024 and is projected to exhibit 5.6% CAGR from 2025 to 2034. The market is experiencing growth due to the increasing occurrence of cardiovascular diseases (CVDs) and the aging population. Cardiovascular disease is one of the primary causes of mortality worldwide, and it is emerging as a significant concern for public health. With the global increase in risk factors such as hypertension, diabetes, obesity, and sedentary lifestyles, CVDs have become the leading cause of mortality worldwide.

Angiography is both a diagnostic and therapeutic procedure that is critical for the management of CVDs, as it offers precise visualization of blood vessels for the detection of blockages and other abnormalities. WHO reports that about 17.9 million people die from CVD every year, which is 32 % of deaths in the world. An increasing demand for timely and accurate diagnosis, together with growth in minimally invasive procedures, has surged the adoption of advanced angiography systems. Further, government initiatives and technological advancements in imaging modalities are further supporting this trend, ensuring strong market growth.
 

Angiography equipment is a specialized medical device that is used to perform angiography, a diagnostic imaging procedure that helps to visualize interior areas of blood vessels and organs. This type of procedure requires an x-ray machine, the use of contrast agents, catheters, and a fluoroscopic system, which make it possible to see the movement of blood in vessels as well as determine if there are any blockages, aneurysms, narrowed vessels, and other deviations. Angiography equipment is commonly used in cardiovascular, neurovascular, and peripheral artery interventions.
 

Angiography Equipment Market Trends

• Vendors in the market are focusing towards offering high-tech imaging systems that are being designed to optimize the level of accuracy and ensure patient safety during a diagnosis and medical procedure. For example, advancements in flat panel detectors over traditional image intensifiers in angiography systems are improving image quality while lowering the amount of radiation used. These innovations have resulted to improve real-time imaging, specifically during complex vascular procedures.
   
• Moreover, the presence of hybrid MRI or CT integrated with angiography devices allows for general imaging, which aids in detailed functional and anatomical examination. There is a significant increase in the use of these systems in interventional cardiology and oncology.
   
• Moreover, vendors are also integrating AI-powered imaging applications into angiography systems for advanced image analysis, measurement automation, and error minimization. This technological advancement is helping to improve workflow efficiency and increase the accuracy of abnormality detection.
   
• In addition, progress in 3D angiography has enabled enhanced representation of complex vascular details that is helping in accurate planning prior to the interventional procedures. 3D angiography is specifically finding substantial use in neuroangiography and endovascular procedures.
   

Trump Administration Tariffs

• Given the renewed tariffs by U.S. government specifically on China-based medical devices, components, and electronics, the angiography equipment market is expected to endure some strategic supply chain cost realignments over the forecast period.
   
• As there is no indication that the tariffs on import x-ray tubes, digital x-ray detectors, imaging sensors, and display systems from China and other regions are expected to be lifted or eased. Hence, angiography system manufacturers, especially those that are U.S. assemblers or globally sourcing, are likely to increase their spending on components. This will result in an elevation of the cost of angiography equipment during the forecast period. 
   
• OEMs and manufacturers like GE HealthCare, Siemens Healthineers, and Koninklijke Philips will continue to expand their supply chain diversification by shifting component sourcing from China to other Southeast Asian countries with lower terrifs such as Vietnam and India. 
   
• Furthermore, U.S. hospital and ASC operators may put off upgrades or adopt leasing/managed service models to counterbalance increased capital costs.
   

Angiography Equipment Market Analysis

Based on product, the market is segmented into angiography systems, catheters, guidewire, balloons, contrast media, vascular closure devices, and angiography accessories. The angiography systems segment dominates the market with a share of 22.1% in 2024.
 

• Angiography systems are finding growing utilization across diagnostic and interventional procedures for high resolution imaging to facilitate detailed visualization of blood vessels.  Their accuracy and real-time imaging capabilities for heart, blood vessels, brain, and tumor diseases are aiding diagnosis and treatment in a multitude of hospitals and diagnostic centers across the globe. This is further contributing to the growth of the segment.
   
• Moreover, continuing improvement of low-dose radiation, flat-panel detectors, and 3D imaging technologies provides further functional and efficiency improvements to angiography systems. For example, in August 2023, Canon Medical introduced the Alphenix Evolve in Europe, a device that improves imaging quality while reducing procedure time and radiation exposure during advanced and routine procedures.
   
• These advancements serve a wide range of applications, including coronary, endovascular, and neurovascular procedures, driving the widespread adoption of angiography systems across healthcare settings.
   

Based on technology, the angiography equipment market is segmented into X-ray, MRA, and CT. The X-ray segment is further sub-segmented into image intensifiers and flat-panel detectors. The X-ray segment dominated the market with a share of 40.9% in 2024.
 

• Stent placements and angioplasty procedures are done using X-ray image guidance. X-ray angiography provides the most accurate image of blood vessels which is critical to coronary and other endovascular procedures. This imaging modality is widely used in clinical practice because of its multifaceted contributions.
   
• Moreover, X-ray remains the most widely used imaging method in the field of angiography. As a result, developments in imaging technologies such as the introduction of flat-panel detectors and digital subtraction angiography (DSA) have greatly enhanced the quality of the images obtained while decreasing radiation dose. These advances have contributed to an increase in the accuracy of diagnostic procedures using X-ray angiography. Further increasing the adoption of these systems.
   

Based on procedure, the angiography equipment market is segmented into intra- coronary angiography, endovascular angiography, neuroangiography, onco-angiography, and other angiography procedures. The intra- coronary angiography segment dominated the market with a share of 28.6% in 2024.
 

• Coronary artery diseases (CAD) remain one of the leading causes of death globally, with millions of cases diagnosed each year. Intra-coronary angiography is the gold standard for assessing coronary blockages and guiding interventions such as stent placement and angioplasty, making it indispensable in cardiology.
   
• Moreover, technological innovations like fractional flow reserve (FFR)-guided angiography and optical coherence tomography (OCT) have enhanced the diagnostic accuracy and therapeutic precision of intra-coronary angiography. These advancements ensure the segment's continued leadership in the market.
   
• Furthermore, compared to CT or MR angiography, X-Ray Angiography has superior spatial resolution that is useful for imaging coronary arteries and neurovascular applications. Owing to growing prevalence of CVDs, the demand for coronary artery imaging is increasing, which is further contributing to the segment's growth.
   

Based on application, the angiography equipment market is segmented into diagnostics and therapeutics. The diagnostics segment dominated the market with a share of 60.3% in 2024.
 

• Growing prevalence of cardiovascular diseases (CVDs), neurovascular disorders, and cancer has surged the focus of healthcare settings and regulatory agencies towards early and accurate diagnosis to improve patient outcomes.
   
• As per WHO, assessing, identifying, and treating cancer earlier improves patient outcomes. Early detection improves cancer outcomes since they can receive help at the earliest stage, which makes it easier for doctors to help their patients overcome the illness. As a result, the demand for timely diagnosis is increasing.
   
• Additionally, angiography is widely recognized as a first-line investigation tool for reliably diagnosing wide range of cardiovascular, neurovascular, and peripheral vascular conditions.
   
• In addition, the growth of healthcare technology and awareness initiatives has resulted in an upsurge in routine checkups for at-risk population. As part of preventive healthcare, diagnostic procedures like coronary angiography and neuroangiography have become  critical, further supporting dominance of the segment.
   

Learn more about the key segments shaping this market

Download Free PDF

Based on end use, the angiography equipment market is segmented into hospitals and clinics, diagnostic and imaging centers, and other end users. The hospitals and clinics segment dominated the market with a share of 48.1% in 2024.
 

• Hospitals and clinics are involved in performing complex angiographic procedures, as they own the required equipment and have trained staff in specialized units. Their ability to multitask at diagnostic and therapeutic levels with a broad scope of angiographic services makes them a preferred choice for such procedures.
   
• Furthermore, hospitals are capable of handling high volume acute conditions such as myocardial infarction or stroke where angiography serves an important purpose as both a diagnostic and therapeutic procedure.
   
• Together with emergency care units and surgery teams, hospitals are able to offer faster and better treatment, which increases the demand of angiography equipment across these acute care settings.
   

In 2024, the U.S. led the North America angiography equipment market, generating a revenue of about USD 5 billion.
 

• In the U.S., the market is mainly impacted by the increasing prevalence of CVDs and the adoption of sophisticated diagnostic technologies across the healthcare settings. The CDC indicates that in 2022, CVDs caused a death every 33 seconds in the country. 
   
• This has increased the concern leading to government attention with regard to the high prevalence of CVDs and resulted in awareness campaign strategy (such as  The Million Hearts Initiative, and The Heart Truth and Red Dress). These initiatives have shifted the focus of at-risk patients toward proactive screening, thereby increasing the need for angiography systems in the U.S. 
   
• Moreover, the increasing focus on developing cutting-edge healthcare facilities like hospitals, as well as the trend towards less invasive surgery, is increasing the use of angiography both for diagnosing and treating conditions.
   

Europe: The UK is set to see a robust expansion in its angiography equipment market from 2025 to 2034.
 

• The elderly population in the UK is more susceptible to cardiovascular diseases which increases the need for advanced imaging equipment for proper diagnosis and effective management of such diseases, increasing the need for angiography equipment. According to the House of Commons Library, in 2022 about 12.7 million people were aged 65 and above, which accounts to 19% of the total population being geriatric in the UK.
   
• Furthermore, schemes such as the NHS Long Term Plan, that focuses on reducing mortality associated with cardiac issues and reducing premature deaths, has led to an increased emphasis on the installation of angiography systems throughout healthcare institutions in the UK, driving the revenue growth in the country.
   

Asia Pacific: Japan's angiography equipment market is set for lucrative growth from 2025 to 2034.
 

• High demand for percutaneous coronary internation (PCI) procedures in Japan is driving the demand for angiography equipment across healthcare settings. According to the August 2024 article published by Cardiovascular Intervention and Therapeutic Journal, about 250,000 PCI procedures are performed annually in Japan.
   
• Also, Japan is known for its advancements in medical imaging technology, which has accelerated the adoption of next-generation angiography systems offering enhanced resolution and reduced radiation exposure, particularly in specialized centers.
   
• Furthermore, Japan has large share of population (30% of total population in 2023, as per World Bank Group) that are aged 65 and above. The elderlies are considered at-risk patients for cardiovascular diseases, owing to which the demand for cardiac diagnosis is high in the country, contributing to the market.
   

Middle East and Africa: Saudi Arabia's angiography equipment market is expected to witness substantial growth during the forecast period.
 

• Rising rates of diabetes, hypertension, and obesity in Saudi Arabia have significantly contributed to the increased incidence of cardiovascular diseases, driving the demand for angiography equipment in diagnostic and treatment settings.
   
• For instance, according to the 2024 study published by Journal of Saudi Heart Association, Saudi Arabia has one of the highest age-standardized CVD mortality in the GCC region, estimated between 329.5 and 379.6 per 100,000. The increasing prevalence of cardiovascular diseases is leading to higher demand for angiography procedures for the early diagnosis of cardiovascular issues.
   
• In addition, owing to implementation of Saudi Vision 2030, there is a shift in focus towards the incorporation of sophisticated advanced treatment technologies such as advanced angiography equipment across healthcare settings in Saudi Arabia.
   

Angiography Equipment Market Share

The market is moderately concentrated with top 5 companies such as GE Healthcare, Siemens Healthineers, Koninklijke Philips, Canon Medical System, and Boston Scientific sharing about 45% of the market. The market has presence of both international and domestic manufacturers offering advanced devices to meet the growing demand for accurate diagnostics and treatment for cardiovascular and neurological disorders. The competition in this field is driven by ongoing technological advancements, regulatory compliances and certifications, and the capability to offer alternatives tailored to the specific requirements of every hospital, diagnostic centre, or specialty clinic.
 

In developing countries where affordability is a key consideration driving the procurement decisions for ECG device among end users, multinational companies faces challenge for delivering cost-effective angiography systems. Regional companies thus focus on pricing strategies to gain competitive edge.
 

Angiography Equipment Market Companies

Some of the eminent market participants operating in the angiography equipment industry include:

• Abbott
• Angiodynamics
• B. BRAUN
• Boston Scientific
• Canon Medical System
• Cardinal Health
• Cordis
• GE Healthcare
• Koninklijke Philips
• Medtronic
• Merit Medical
• Microport Scientific
• Shimadzu Corporation
• Siemens Healthineers
• Toshiba Medical System
   
• GE HealthCare offers high precision angiography systems that are integrated with AI features. These key focus of the company is towards offering clinically versatile systems that can support cardiology, oncology, and neurology across hybrid settings or operation room.
   
• Siemens Healthineers offers High-end robotic C-arm platforms that features ultra-high-resolution 3D imaging along with real time 3D image guidance. The company also operates through direct distribution model across its key markets to ensure efficient control over sales and service quality.
   
• Koninklijke Philips focuses on establishing closed ecosystems for its product across healthcare settings, offering bundled packages of angiography units, monitors, software, and patient management tools. The company also has a strong distribution network.
   

Angiography Equipment Industry News:

• In October 2024, Shimadzu Corporation announced the development of SMART Voice, a voice recognition function designed for its Trinias series with SCORE Opera angiography systems. This innovative feature aims to enhance the efficiency of catheterization procedures, significantly reducing the operational burden on physicians and healthcare personnel.
   
• In September 2024, Koninklijke Philips announced the FDA approval for its enhanced LumiGuide guidewire, now available in a 160 cm version, which utilizes the innovative Fiber Optic RealShape (FORS) technology. This new guidewire was first used in a complex aortic aneurysm repair operation, marking a significant milestone as the 1,000th patient treated using this advanced technology since its clinical.
   
• In August 2023, Canon Medical System announced the launch of Alphenix Evolve edition in Europe. The system is intended for use in percutaneous coronary intervention (PCI) and structural heart disease procedures. The product features noise reduction and multifrequency processing that enable clear fluoroscopic imaging, which can deliver a two-times–higher contrast-to-noise ratio compared to conventional image processing.
   

The angiography equipment market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Angiography systems
• Catheters
• Guidewire
• Balloons
• Contrast media
• Vascular closure devices
• Angiography accessories

Market, By Technology 

• X-ray
  • Image intensifiers
  • Flat-panel detectors
• MRA
• CT

Market, By Procedure  

• Coronary angiography
• Endovascular angiography
• Neuroangiography
• Onco-angiography
• Other angiography procedures

Market, By Application

• Diagnostics
• Therapeutics

Market, By End Use

• Hospitals and clinics
• Diagnostic and imaging centers
• Other end use

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada
• Europe 
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherland
• Asia Pacific 
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America 
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa 
  • South Africa
  • Saudi Arabia
  • UAE